11 results about "Amenorrhea" patented technology

The present application relates to a kind of traditional Chinese medicine composition for regulating irregular menstruation, traditional Chinese medicine powder bag and ironing heating bag.The traditional Chinese medicine composition includes the following weight parts components: 7-11 parts of raw rehmannia, 7-11 parts of Guangyujin, 1-5 parts of licorice, 7-11 parts of medlar, 4-8 parts of dried tangerine or orange peel, 7-11 parts of kudzu root, 7-11 parts of white atractylodes, 1-5 parts of sanqi.The ironing heating bag includes traditional Chinese medicine powder bag, heating layer and support, and the traditional Chinese medicine powder bag, heating layer and support are sequentially bonded to form sandwich structure;The ironing heating bag is attached to the user's abdominal segment of belt pulse.Compared with prior art, the traditional Chinese medicine composition and ironing heating bag of the present application act on human body belt pulse, have the effects of warming meridian and dispelling cold, promoting blood circulation to remove blood stasis, regulating belt pulse, and have significant curative effect on irregular menstrual cycle, less menstrual flow, blood stasis, dysmenorrhea, amenorrhea and other symptoms.

The FSH and LH fusion protein is composed of a first polypeptide, a second polypeptide, a third polypeptide and a fourth polypeptide. Wherein the first polypeptide comprises a beta subunit of FSH, a beta subunit of LH, a hinge, a CH2 structural domain and a CH3 structural domain, or the beta subunit of LH, the beta subunit of FSH, the hinge, the CH2 structural domain and the CH3 structural domain from an N terminal to a C terminal; the second polypeptide comprises a hinge, a CH2 structural domain and a CH3 structural domain from the N terminal to the C terminal; the third polypeptide and the fourth polypeptide are both composed of alpha subunits of FSH. The FSH and LH fusion protein has the functions of FSH and LH at the same time; meanwhile, compared with recombinant or natural FSH and LH, the heterodimer has a longer half-life period, can complement gonadotropin in a long-acting, mild and continuous manner, and is suitable for various FSH and LH deficiency related diseases such as male hypogonadotropin gonad hypofunction, female pituitary insufficiency, hypogonadotropin amenorrhea or hypogonadotropin infertility. The medicine economy is better, and the patient compliance is better.

This invention relates to methods for treating endometriosis and providing effective contraception. Specifically, it relates to drospirenone in methods for treating endometriosis, endometriosis-associated pelvic pain (EAPP), and / or dysmenorrhea, the method comprising administering drospirenone in a biphasic regimen. The invention also relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, and to pharmaceutical compositions and devices comprising drospirenone administered in such a biphasic regimen.

The invention relates to the technical field of traditional Chinese medicines, and discloses a classic prescription for treating hypoovarian reserve function, which is prepared from the following raw materials: 30 to 40g of Chinese yam, 20 to 30g of semen cuscutae, 10 to 20g of fructus lycii, 10 to 15g of radix achyranthis bidentatae, 10 to 20g of codonopsis pilosula, 10 to 20g of poria cocos, 20 to 30g of malt, 10 to 15g of angelica sinensis and 10 to 30g of radix puerariae. The classical prescription for treating the hypoovarian reserve function has a positive curative effect, and modern network pharmacology also scientifically proves that active ingredients such as quercetin, daidzein, kaempferol and the like contained in the kidney-tonifying and menstruation-regulating prescription are flavonoid compounds from the aspect of action mechanism, so that the prescription has very good anti-inflammatory and anti-oxidative stress ovarian protection effects; the application range is wide, clinical manifestations of patients with the ovarian reserve function decline are generally hypomenorrhea, menoxenia, amenorrhea, infertility or perimenopausal symptoms, and the kidney tonifying and menstruation regulating prescription has a certain regulating effect on the hypomenorrhea.

This invention discloses a temperature-adjustable menstrual-inducing patch, belonging to the field of medical dressing technology, to solve the problems of existing menstrual-inducing products, such as non-adjustable temperature, low efficiency, poor adhesion, and inconvenience of use. The patch has a layered, integrated structure, consisting of a control layer, a dressing layer, and an isolation layer from the outside in, suitable for use around the navel. The control layer integrates a charging module, a temperature regulation module, a heating module, and a main control chip; the dressing layer uses a breathable mesh to wrap a menstrual-inducing herbal composition, achieving synergistic menstrual-inducing effects through heating and medication. This invention features a compact structure, convenient operation, high safety, and no side effects. It can be used as an auxiliary tool for inducing menstruation in amenorrhea patients, suitable for home and travel use, effectively improving menstrual-inducing efficiency and user comfort.

The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and / or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition that warms the uterus, promotes menstruation, and eliminates masses. The TCM composition comprises the following herbs: safflower, peach kernel, bupleurum, leech, sparganium, turmeric, immature bitter orange, chuanxiong rhizome, cinnamon twig, red peony root, peony bark, cyperus rhizome, lindera root, fennel, sappanwood, aconite root, and cuscuta seed. This invention also proposes a method for preparing an external application of the TCM composition and its application. The TCM composition of this invention is suitable for treating gynecological conditions such as amenorrhea, ovarian cysts, polycystic ovary syndrome, and oligomenorrhea. It features a rigorous formulation, combining tonifying and purging methods to address both the symptoms and root cause. Based on years of clinical experience, it demonstrates significant efficacy, minimal irritation, and no side effects.

The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and / or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.

The invention belongs to the technical field of traditional Chinese medicine, and discloses a traditional Chinese medicine composition for improving premature ovarian failure, the traditional Chinese medicine composition is formed by combining an oral medicine and an external application patch, and the oral medicine is prepared from the following medicinal materials: adenophora stricta, radix ophiopogonis, angelica sinensis, medlar, Chinese yam, radix rehmanniae recen, dogwood, glossy privet fruit, eclipta, ligusticum wallichii, radix paeoniae alba, semen cuscutae, schisandra chinensis, raspberry and mulberry. The external application patch is prepared from the following traditional Chinese medicinal materials: adenophora stricta, radix ophiopogonis, angelica sinensis, fructus lycii, Chinese yam, radix rehmanniae recen, dogwood, glossy privet fruit, eclipta, ligusticum wallichii, radix paeoniae alba, semen cuscutae, schisandra chinensis, raspberry, mulberry, herba epimedii, salvia miltiorrhiza, red ginseng, borneol and fructus evodiae. The traditional Chinese medicine composition disclosed by the invention is scientific and reasonable in compatibility, has the effects of exuberant kidney essence, sufficient liver blood, nourishing Chong and Ren channels and full blood sea, can nourish liver yin by nourishing kidney yin, regulate and treat symptoms such as premature ovarian failure, amenorrhea, hypomenorrhea, deficiency of liver-yin and kidney-yin, hectic fever and sweating, insomnia, dysphoria and irritability and improve ovarian functions, and is remarkable in clinical effect.

The present invention relates to drospirenone for use in a method for treating endometriosis, endometriosis associated pelvic pain (EAPP) and / or dysmenorrhea, comprising administering drospirenone in a biphasic regimen. The present invention furthermore relates to the use of drospirenone administered in such a biphasic regimen as a contraceptive and for inducing amenorrhea, as well as to a pharmaceutical composition and a kit comprising drospirenone administered in such a biphasic regimen.

The present application relates to a kind of gonadotropin releasing hormone antagonists, it has the antagonistic activity to gonadotropin releasing hormone, and can be used to prevent or treat sex hormone-dependent diseases, such as benign prostatic hypertrophy, uterine fibroids, endometriosis, uterine fibroids, precocious puberty, amenorrhea, premenstrual syndrome, dysmenorrhea and the like, or its prodrug, or its pharmaceutically acceptable salt, or its hydrate or solvate, and the pharmaceutical composition containing it.